Orchestra BioMed Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orchestra BioMed Holdings generated cash of -$46,127,000, which is less than the previous year. Cash used in financing activities reached the amount of $46,215,000 last year. Net change in cash is therefore $10,775,000.
Cash Flow
| 2020 | -26.18M | 26.96M | 10M |
|---|---|---|---|
| 2021 | -19.42M | 13.01M | -3.99M |
| 2022 | -29.28M | -64.12M | 103.25M |
| 2023 | -46.12M | 10.68M | 46.21M |
OBIO Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 19.78M | 1.75M | 20.34M | 9.56M |
Operating activities | ||||
Net income | -49.12M | -33.60M | -23.01M | -21.35M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 287K | 222K | 181K | 137K |
Stock-based compensation expense | 7.62M | 3.41M | 302K | 221K |
| Deferred income tax benefit | 7.62M | 3.41M | 302K | 221K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -3K | 25K | 47K | -79K |
Inventories | 131K | -208K | 1K | -26K |
Accounts payable | 145K | 183K | 1.07M | -2.60M |
Cash generated by operating activities | -46.12M | -29.28M | -19.42M | -26.18M |
Investing activities | ||||
Purchases Of Investments | -142.03M | -63.53M | -213K | -15.62M |
Investments In Property Plant And Equipment | -78K | -591K | -274K | -539K |
Acquisitions Net | 0 | -29.06M | -13.29M | -27.50M |
Cash generated by investing activities | 10.68M | -64.12M | 13.01M | 26.96M |
Financing activities | ||||
Common Stock Issued | 254K | 109.83M | 0 | 162.28M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | -10.84M | 3.55M | -4M | -10M |
Cash used in financing activities | 46.21M | 103.25M | -3.99M | 10M |
Net Change In Cash | 10.77M | 18.02M | -10.40M | 10.78M |
Cash at end of period | 30.55M | 19.78M | 9.93M | 20.34M |
| Data source |